Preparation of protamine cationic nanobubbles and experimental study of their physical properties and invivo contrast enhancement

Ultrasound in Medicine and Biology

Volumn 39, Issue 11, 2013, Pages 2147-2157

  Tong, Hai Peng ^a   Wang, Luo Fu ^b   Guo, Yan Li ^a   Li, Lang ^a   Fan, Xiao Zhou ^a   Ding, Jun ^a   Huang, Hai Yun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cationic nanobubble; Contrast enhanced ultrasound; Gene transfection; Protamine

Indexed keywords

GENE THERAPY; LIPOSOMES; MOLECULAR BIOLOGY; PHYSICAL PROPERTIES; TUMORS; ULTRASONIC IMAGING; ULTRASONICS;

CONTRAST ENHANCED ULTRASOUND; GENE TRANSFECTION; MECHANICAL OSCILLATIONS; NANO-BUBBLE; PROSTATE CANCER CELLS; PROTAMINE; TRANSFECTION EFFICIENCY; ULTRASOUND IRRADIATION;

LOADING;

ANDROGEN RECEPTOR; DIPALMITOYLPHOSPHATIDYLGLYCEROL; DISTEAROYLPHOSPHATIDYLCHOLINE; LIPOSOME; MACROGOL 400; NANOBUBBLE; PROTAMINE; SMALL INTERFERING RNA; SONOVUE;

ARTICLE; CANCER CELL; CANCER GENE THERAPY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EXPERIMENTAL STUDY; GENE THERAPY; IMAGE ANALYSIS; IN VIVO STUDY; MICROBUBBLE; MICROSCOPE; MOUSE; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; PROSTATE CANCER; ULTRASOUND; ZETA POTENTIAL;

CATIONIC NANOBUBBLE; CONTRAST-ENHANCED ULTRASOUND; GENE TRANSFECTION; PROTAMINE;

ANIMALS; CATIONS; CELL LINE, TUMOR; DIFFUSION; DNA; HUMANS; MALE; MICE; MICE, NUDE; NANOCAPSULES; PROSTATIC NEOPLASMS; PROTAMINES; TRANSFECTION; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 84884533037     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2013.05.016     Document Type: Article

References (33)

1. Apfel R.E., Holland C.K. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol 1991, 17:179-185.
2. Bekeredjian R., Chen S., Frenkel P.A., Grayburn P.A., Shohet R.V. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003, 108:1022-1026.
3. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. Aversatile vector for gene and oligonucleotide transfer into cells in culture and invivo: Polyethylenimine. Proc Natl Acad Sci 1995, 92:7297-7301.
4. de Jong N., Bouakaz A., Frinking P. Basic acoustic properties of microbubbles. Echocardiography 2002, 19:229-240.
5. Eliyahu H., Servel N., Domb A.J., Barenholz Y. Lipoplex-induced hemagglutination: Potential involvement in intravenous gene delivery. Gene Ther 2002, 9:850-858.
6. Endo-Takahashi Y., Negishi Y., Kato Y., Suzuki R., Maruyama K., Aramaki Y. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound. Int J Pharm 2012, 422:504-509.
7. Farrell L.L., Pepin J., Kucharski C., Lin X., Xu Z., Uludag H. Acomparison of the effectiveness of cationic polymers poly-L-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC). Eur J Pharm Biopharm 2007, 65:388-397.
8. Greenleaf W.J., Bolander M.E., Sarkar G., Goldring M.B., Greenleaf J.F. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 1998, 24:587-595.
9. Haag P., Frauscher F., Gradl J., Seitz A., Schafer G., Lindner J.R., Klibanov A.L., Bartsch G., Klocker H., Eder I.E. Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. JSteroid Biochem Mol Biol 2006, 102:103-113.
10. Han S., Mahato R.I., Sung Y.K., Kim S.W. Development of biomaterials for gene therapy. Mol Ther 2000, 2:302-317.
11. Hernot S., Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008, 60:1153-1166.
12. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloid Surface B 2010, 75:1-18.
13. Li L.C., Tian Y.Q. Zeta potential. Encyclopedia of pharmaceutical technology 2002, 3032. Marcel Dekker, New York. 2nd edition. J. Swarbrick, J.C. Boylan (Eds.).
14. Li Y.S., Davidson E., Reid C.N., McHale A.P. Optimising ultrasound-mediated gene transfer (sonoporation) invitro and prolonged expression of a transgene invivo: Potential applications for gene therapy of cancer. Cancer Lett 2009, 273:62-69.
15. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. JControl Release 2000, 65:271-284.
16. Mohammadi Z., Dorkoosh F.A., Hosseinkhani S., Gilani K., Amini T., Najafabadi A.R., Tehrani M.R. Invivo transfection study of chitosan-DNA-FAP-B nanoparticles as a new non viral vector for gene delivery to the lung. Int J Pharm 2011, 421:183-188.
17. Mohan R.R., Sharma A., Cebulko T.C., Tandon A. Vector delivery technique affects gene transfer in the cornea invivo. Mol Vis 2010, 16:2494-2501.
18. Newland B., Tai H., Zheng Y., Velasco D., Di Luca A., Howdle S.M., Alexander C., Wang W., Pandit A. Ahighly effective gene delivery vector-hyperbranched poly(2-(dimethylamino)ethyl methacrylate) from in situ deactivation enhanced ATRP. Chem Commun (Camb) 2010, 46:4698-4700.
19. Nishimura K., Sano M., Ohtaka M., Furuta B., Umemura Y., Nakajima Y., Ikehara Y., Kobayashi T., Segawa H., Takayasu S., Sato H., Motomura K., Uchida E., Kanayasu-Toyoda T., Asashima M., Nakauchi H., Yamaguchi T., Nakanishi M. Development of defective and persistent Sendai virus vector: A unique gene delivery/expression system ideal for cell reprogramming. JBiol Chem 2011, 286:4760-4771.
20. Peng L., Gao Y., Xue Y.N., Huang S.W., Zhuo R.X. Cytotoxicity and invivo tissue compatibility of poly(amidoamine) with pendant aminobutyl group as a gene delivery vector. Biomaterials 2010, 31:4467-4476.
21. Sakurai F., Nishioka T., Yamashita F., Takakura Y., Hashida M. Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system. Euro J Pharm Biopharm 2001, 52:165-172.
22. Schneider M. SonoVue, a new ultrasound contrast agent. Eur Radiol 1999, 9(Suppl 3):S347-S348.
23. Tam P., Monck M., Lee D., Ludkovski O., Leng E.C., Clow K., Stark H., Scherrer P., Graham R.W., Cullis P.R. Stabilized plasmid-lipid particles for systemic gene therapy. Gene Ther 2000, 7:1867-1874.
24. ter Haar GR Ultrasonic contrast agents: Safety considerations reviewed. Euro J Radiol 2002, 41:217-221.
25. Tsai J.T., Furstoss K.J., Michnick T., Sloane D.L., Paul R.W. Quantitative physical characterization of lipid-polycation-DNA lipopolyplexes. Biotechnol Appl Biochem 2002, 36:13-20.
26. Wang H.S., Chen Z.J., Zhang G., Ou X.L., Yang X.L., Wong C.K., Giesy J.P., Du J., Chen S.Y. Anovel micro-linear vector for invitro and invivo gene delivery and its application for EBV positive tumors. PloS One 2012, 7:e47159.
27. Wu G.Y., Wu C.H. Receptor-mediated invitro gene transformation by a soluble DNA carrier system. JBiol Chem 1987, 262:4429-4432.
28. Xiong J., Sun W.J., Wang W.F., Liao Z.K., Zhou F.X., Kong H.Y., Xu Y., Xie C.H., Zhou Y.F. Novel, chimeric, cancer-specific, and radiation-inducible gene promoters for suicide gene therapy of cancer. Cancer 2012, 118:536-548.
29. Yin T., Wang P., Zheng R., Zheng B., Cheng D., Zhang X., Shuai X. Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomedicine 2012, 7:895-904.
30. Yudina A., Lepetit-Coiffe M., Moonen C.T. Evaluation of the temporal window for drug delivery following ultrasound-mediated membrane permeability enhancement. Mol Imaging Biol 2011, 13:239-249.
31. Zhang M., Guo Y., Wang L., Li Y., Li R. Screening and evaluation of a newly designed siRNA targeting androgen receptor. JThird Mil Med Univ 2011, 2459-2462.
32. Zhang S., Xu Y., Wang B., Qiao W., Liu D., Li Z. Cationic compounds used in lipoplexes and polyplexes for gene delivery. JControl Release 2004, 100:165-180.
33. Zhang Y., Chen X., Lan J., You J., Chen L. Synthesis and biological applications of imidazolium-based polymerized ionic liquid as a gene delivery vector. Chem Biol Drug Des 2009, 74:282-288.